Related Experiment Videos
Carcinoid tumor and bariatric surgery.
Ara Keshishian1, John Hamilton, Lily Hwang
1Department of Surgery, Delano Regional Medical Center, 1205 Garces Highway, Suite 303, Delano, CA 93215, USA. keshishiana@gr-ds.com
Obesity Surgery
|February 6, 2003
Summary
Carcinoid tumors, a rare gastrointestinal cancer, were observed with high frequency in patients undergoing gastric reduction-duodenal switch surgery. Research is needed to explore a possible link between morbid obesity and carcinoid tumor development.
Area of Science:
- Gastroenterology
- Oncology
- Bariatric Surgery
Background:
- Carcinoid tumors are rare neuroendocrine neoplasms originating in the gastrointestinal tract.
- Gastric reduction-duodenal switch (GRDS) is a bariatric procedure for severe obesity.
Observation:
- A notable increase in carcinoid tumor incidence was observed in patients undergoing GRDS.
- This observation was made within a specific patient population during the surgical procedure.
Findings:
- The study identified a higher-than-expected occurrence of carcinoid tumors in individuals who underwent GRDS.
- This suggests a potential association that warrants further investigation.
Implications:
- Further research is crucial to determine if a correlation exists between morbid obesity and carcinoid tumors.
- Understanding this potential link could impact patient screening and management strategies for bariatric surgery candidates.